How antimalarial drug resistance affects post-treatment prophylaxis

Malaria Journal

Volumn 7, Issue , 2008, Pages

  White, Nicholas J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DEETHYLAMODIAQUINE; MEFLOQUINE; PIPERAQUINE; PYRONARIDINE; TAFENOQUINE;

DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SENSITIVITY; HUMAN; IN VITRO STUDY; MALARIA; POST TREATMENT PROPHYLAXIS; PROPHYLAXIS; REVIEW; ANTIBIOTIC PROPHYLAXIS; DRUG EFFECT; DRUG RESISTANCE; IMMUNITY; PHARMACOKINETICS; RECURRENT DISEASE;

ANTIBIOTIC PROPHYLAXIS; ANTIMALARIALS; DRUG RESISTANCE; HUMANS; IMMUNITY; MALARIA; PHARMACOKINETICS; RECURRENCE;

EID: 40149110041     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-9     Document Type: Review

References (18)

1. Intermittent presumptive treatment for malaria. A better understanding of the pharmacodynamics will guide more rational policymaking. NJ White, PLoS Medicine 2005 2 29 33 10.1371/journal.pmed.0020003
2. The assessment of antimalarial drug efficacy. NJ White, Trends Parasitol 2002 18 458 464 10.1016/S1471-4922(02)02373-5 12377597
3. Treatment of Plasmodium falciparum malaria with pyrimethamine- sulfadoxine: selective pressure for resistance is a function of long elimination half-life. WM Watkins M Mosobo, Trans R Soc Trop Med Hyg 1993 87 75 78 10.1016/0035-9203(93)90431-O 8465404
4. Pharmacokinetic parameters affecting the evolution of drug-resistance in malaria. The role of the terminal elimination half-life. I Hastings WM Watkins NJ White, Philos Trans R Soc Lond B Biol Sci 2002 357 505 519 12028788 10.1098/rstb.2001.1036
5. The origins of antimalarial drug resistance. IM Hastings, Trends Parasitol 2004 20 512 518 10.1016/j.pt.2004.08.006 15471702
6. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy a systematic review. FO ter Kuile AM van Eijk SJ Filler, JAMA 2007 297 2603 16 10.1001/jama.297.23.2603 17579229
7. Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? A Vallely L Vallely J Changalucha B Greenwood D Chandramohan, Malar J 2007 6 16 17306014 10.1186/1475-2875-6-16
8. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. WM Watkins EK Mberu PA Winstanley C Plowe, Parasitol Today 1997 13 459 464 10.1016/S0169-4758(97)01124-1 15275132
9. Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. JA Simpson L Aarons WE Collins G Jeffery NJ White, Parasitology 2002 124 247 263 10.1017/S0031182001001202 11922427
10. Mathematical model of the first wave of Plasmodium falciparum asexual parasitemia in non-immune and vaccinated individuals. K Dietz G Raddatz L Molineaux, Am J Trop Med Hyg 2006 75 2 Suppl 46 55 16931815
11. Coartem (artemether-lumefantrine) in Africa : the beginning of the end? IM Hastings SA Ward, J Infect Dis 2005 192 1303 4 10.1086/432554 16136476
12. Chloroquine resistance in Plasmodium vivax. JK Baird, Antimicrob Agents Chemother 2004 48 4075 4083 15504824 10.1128/AAC.48.11.4075-4083.2004
13. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. AR Hasugian HL Purba E Kenangalem RM Wuwung EP Ebsworth R Maristela PM Penttinen F Laihad NM Anstey E Tjitra RN Price, Clin Infect Dis 2007 44 1067 74 10.1086/512677 17366451
14. Reducing the burden of malaria in pregnancy by preventive strategies. C Menendez U D'Alessandro FO ter Kuile, Lancet Infect Dis 2007 7 126 135 10.1016/S1473-3099(07)70024-5 17251083
15. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. KI Barnes F Little PJ Smith A Evans WM Watkins NJ White, Clin Pharmacol Ther 2006 80 582 596 10.1016/j.clpt.2006.08.016 17178260
16. Nahlen BL, Steketee R, Nettey H: Pharmacokinetics of sulfadoxine and pyrimethamine in HIV-infected and uninfected pregnant women in western Kenya. MD Green AM van Eijk FO Kuile J Ayis ME Parise PA Kager, J Infect Dis 196 1403 8 10.1086/522632 17922406
17. White NJ, Stepniewska K, Barnes K, Price RN, Simpson J. Simplified antimalarial therapeutic monitoring: using the Day 7 drug level? NJ White K Stepniewska K Barnes RN Price J Simpson, Trends Parasitol
18. History, dynamics, and public health importance of malaria parasite resistance. AO Talisuna P Bloland U D'Alessandro, Clin Microbiol Rev 2004 17 235 254 14726463 10.1128/CMR.17.1.235-254.2004